---
schema_version: "secwatch.filing_event.v1"
accession: "0000920148-24-000029"
form_type: "8-K"
ticker: "LH"
cik: "0000920148"
company_name: "LABCORP HOLDINGS INC."
filed_at: "2024-04-25T23:59:59+00:00"
generated_at: "2026-06-03T09:03:48.428286+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Labcorp Q1 adj EPS $3.68 vs $3.46 YoY; raises FY guidance midpoint

## Summary
- Revenue $3.18B (+4.6% YoY); organic base business grew 6.7%.
- Diluted EPS $2.69 vs $2.34; adjusted EPS $3.68 vs $3.46.
- FY2024 adjusted EPS guidance raised to $14.45-$15.35 (prev $14.30-$15.40); FCF reaffirmed $1.0-$1.15B.
- Acquisitions: selected Invitae assets, agreed to buy BioReference Health diagnostic assets, closed three deals including Baystate Health and Providence.
- New holding company structure May 17; Labcorp Holdings Inc. replaces Labcorp as public entity; ticker LH unchanged; $0.72 dividend payable June 12.

## SEC filing metadata
- accession: 0000920148-24-000029
- form_type: 8-K
- ticker: LH
- cik: 0000920148
- company_name: LABCORP HOLDINGS INC.
- filed_at: 2024-04-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/920148/000092014824000029/0000920148-24-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/920148/000092014824000029/lh-20240425.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000920148-24-000029
- JSON: https://secwatch.observer/filing/0000920148-24-000029.json
- Plain text: https://secwatch.observer/filing/0000920148-24-000029.txt

## Key facts
- Earnings Releases
  LABCORP HOLDINGS INC. reported first quarter ended March 31, 2024 results: revenue $3.18 billion, net income $228.3 million, EPS $2.69. Guidance raised.
  - Period: first quarter ended March 31, 2024
  - Revenue: $3.18 billion
  - Net income: $228.3 million
  - EPS: $2.69
  - Guidance: raised
  - Result: reported results
  source text: Labcorp Announces 2024 First Quarter Results Updates Full-Year Guidance • Results from Continuing Operations for first quarter 2024 versus last year: ◦ Revenue: $3.18 billion versus $3.04 billion or up 4.6% | Base Business grew 6.7% ◦ Diluted EPS: $2.69 versus $2.34 ◦ Adjusted EPS: $3.68 versus $3.46 • Full-Year 2024 Guidance: Raised midpoint and
  evidence_url: https://www.sec.gov/Archives/edgar/data/920148/000092014824000029/0000920148-24-000029-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.